This information on IL-8 and CD70, let to the generation of CD70-targeting CAR with a modified IL-8 receptor (called 8R-70CAR) that let to complete tumor regression of advance cancers in pre-clinical studies, including glioblastoma (144). This evidence concerns the gene CXCL8 and neoplasm.